Dominant myelopoietic effector functions mediated by chemokine receptor CCR1

被引:84
作者
Broxmeyer, HE
Cooper, S
Hangoc, G
Gao, JL
Murphy, PM
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Immunol Microbiol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[4] Walther Canc Inst, Indianapolis, IN 46208 USA
[5] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
CC chemokine receptor 1; macrophage inflammatory protein 1 alpha; progenitor cells; proliferation; mobilization;
D O I
10.1084/jem.189.12.1987
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Macrophage inflammatory protein (MIP)-1α, a CC chemokine, enhances proliferation of mature subsets of myeloid progenitor cells (MPCs), suppresses proliferation of immature MPCs, and mobilizes mature and immature MPCs to the blood. MIP-1α binds at least three chemokine receptors. To determine if CCR1 was dominantly mediating the above activities of MIP-1α CCR1-deficient (-/-) mice, produced by targeted gene disruption, were used. MIP-1α enhanced colony formation of marrow granulocyte/macrophage colony- forming units (CFU-GM), responsive to stimulation by granulocyte/macrophage colony-stimulating factor (GM-CSF), and CFU-M, responsive to stimulation by M-CSF, from littermate control CCR1(+/+) but not CCR1(-/-) mice. Moreover, MIP-1α did not mobilize MPCs to the blood or synergize with G-CSF in this effect in CCR1(-/-) mice. However, CCR1(-/-) mice were increased in sensitivity to MPC mobilizing effects of G-CSF. Multi-growth factor- stimulated MPCs in CCR1(-/-) and CCR1(+/+) marrow were equally sensitive to inhibition by MIP-1α. These results implicate CCR1 as a dominant receptor for MIP-1α enhancement of proliferation of lineage-committed MPCs and for mobilization of MPCs to the blood. CCR1 is not a dominant receptor for MIP- lα suppression of MPC proliferation, but it does negatively impact G-CSF- induced MPC mobilization.
引用
收藏
页码:1987 / 1992
页数:6
相关论文
共 27 条
[1]
Chemokines and leukocyte traffic [J].
Baggiolini, M .
NATURE, 1998, 392 (6676) :565-568
[2]
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice [J].
Boring, L ;
Gosling, J ;
Chensue, SW ;
Kunkel, SL ;
Farese, RV ;
Broxmeyer, HE ;
Charo, IF .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2552-2561
[3]
BROXMEYER HE, 1990, BLOOD, V76, P1110
[4]
MYELOPOIETIC ENHANCING EFFECTS OF MURINE MACROPHAGE INFLAMMATORY PROTEIN-1 AND PROTEIN-2 ON COLONY FORMATION INVITRO BY MURINE AND HUMAN-BONE MARROW GRANULOCYTE MACROPHAGE PROGENITOR CELLS [J].
BROXMEYER, HE ;
SHERRY, B ;
LU, L ;
COOPER, S ;
CAROW, C ;
WOLPE, SD ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1583-1594
[5]
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1α, in a phase I clinical trial in patients with relapsed/refractory breast cancer [J].
Broxmeyer, HE ;
Orazi, A ;
Hague, NL ;
Sledge, GW ;
Rasmussen, H ;
Gordon, MS .
BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (02) :14-30
[6]
Involvement of interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: Evidence from mice lacking the murine IL-8 receptor homologue [J].
Broxmeyer, HE ;
Cooper, S ;
Cacalano, G ;
Hague, NL ;
Bailish, E ;
Moore, MW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1825-1832
[7]
BROXMEYER HE, 1993, J IMMUNOL, V150, P3448
[8]
Broxmeyer HE, 1999, CONT CANC RES, P263
[9]
Broxmeyer HE, 1999, CYTOKINES IN THE TREATMENT OF HEMATOPOIETIC FAILURE, P1
[10]
BIOLOGICAL AND STRUCTURAL-PROPERTIES OF MIP-1-ALPHA EXPRESSED IN YEAST [J].
CLEMENTS, JM ;
CRAIG, S ;
GEARING, AJH ;
HUNTER, MG ;
HEYWORTH, CM ;
DEXTER, TM ;
LORD, BI .
CYTOKINE, 1992, 4 (01) :76-82